1046031

Agios Pharmaceuticals, INC. — FEI 3012469070

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization